Bupe more ‘cost-effective’ than methadone during pregnancy

Alison Knopf
{"title":"Bupe more ‘cost-effective’ than methadone during pregnancy","authors":"Alison Knopf","doi":"10.1002/adaw.34654","DOIUrl":null,"url":null,"abstract":"<p>Researchers have looked at whether treatment with methadone or buprenorphine is better in terms of cost-effectiveness outcomes on low birth weight and preterm birth on newborns of mothers treated for opioid use disorder (OUD). The study, “Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes,” showed that buprenorphine had greater value than methadone during pregnancy based on lifetime models accounting for infant outcomes. However, both methadone and buprenorphine were found valuable for pregnant women with OUD.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 36","pages":"3-4"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34654","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Researchers have looked at whether treatment with methadone or buprenorphine is better in terms of cost-effectiveness outcomes on low birth weight and preterm birth on newborns of mothers treated for opioid use disorder (OUD). The study, “Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes,” showed that buprenorphine had greater value than methadone during pregnancy based on lifetime models accounting for infant outcomes. However, both methadone and buprenorphine were found valuable for pregnant women with OUD.

但在怀孕期间,它比美沙酮更“划算”
研究人员已经研究了美沙酮或丁丙诺啡在治疗阿片类药物使用障碍(OUD)的母亲的低出生体重和早产新生儿的成本效益方面是否更好。这项名为“治疗妊娠期阿片类药物使用障碍的成本效益及其对出生结果的影响”的研究表明,基于考虑婴儿结局的终身模型,丁丙诺啡在妊娠期间比美沙酮更有价值。然而,发现美沙酮和丁丙诺啡对孕妇OUD有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信